Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > Virus destruction

<< Previous

Bullboard Posts

Next >>

Comment by Rumpl3StiltSkinon May 20, 2022 9:56am

142 Views

Post# 34698001

RE:RE:Virus destruction

As I recall, from 2020, the FDA approved 3 viruses under 1 year... Is Covid still considered an emergency? Is it thus considered in Canada? IF so TLT could see a substantial benefit from this tech, and soon! IMO... ;-)

Eoganacht wrote: I believe there's still a long way to go. A phase 1 trial won't happen before 2023 and then there are phases 2 and 3 to get through.

jmm1228 wrote: Given the stubborn persistence and mutation record of Covid, PDT may soon begin the rise in stature as a vital remedy. I expect this aspect of the TLT arsenal to soon attain significant recognition.